Abstract
Platelet endothelial cell adhesion molecule (PECAM-1) is a member of the superfamily of immunoglobulins. This cell adhesion molecule has been implicated to mediate the adhesion and trans-endothelial migration of T lymphocytes/monocytes into the vascular wall, a critical step in the initiation of atherogenesis. Current thinking, however, posits that PECAM-1 by virtue of being a scaffolding molecule may well play a role in several signal transduction reactions. As a consequence, this cell adhesion molecule may be responsible for several biological and pathophysiological functions such as thrombosis, and inflammation. Evidence has also been put forward for a potential role of PECAM-1 in apoptosis and atherosclerosis. This article focuses on the structure of PECAM-1 and its role in intracellular signaling and implications in health and disease.
Similar content being viewed by others
References
DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM: Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151: 671-677, 1997
Newman PJ: The biology of PECAM-1. J Clin Invest 99: 3-8, 1997
Newman PJ: Switched at birth: A new family for PECAM-1. J Clin Invest 103: 5-9, 1999
Fujiwara K, Masuda M, Osawa M, Kano Y, Katoh K: Is PECAM-1 a mechanoresponsive molecule? Cell Struct Funct 26: 11-17, 2001
Gumina RJ, el Schultz J, Yao Z, Kenny D, Warltier DC, Newman PJ, Gross GJ: Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 94: 3327-3333, 1996
Kirschbaum NE, Gumina RJ, Newman PJ: Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84: 4028-4037, 1994
Sun J, Paddock C, Shubert J, Zhang HB, Amin K, Newman PJ, Albelda SM: Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization. J Cell Sci 113: 1459-1469, 2002
Serebruany VL, Murugesan SR, Pothula A, Atar D, Lowry DR, O'Connor CM, Gurbel PA: Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur J Heart Fail 1: 243-249, 1999
Serebruany VL, Murugesan SR, Pothula A, Semaan H, Gurbel PA: Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain. Cardiology 91: 50-55, 1999
Gurbel PA, Serebruany VL, Shustov AR, Dalesandro M, Gumbs CI, Grablutz LB, Bahr RD, Ohman EM, Topol EJ: Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis. Coron Artery Dis 9: 451-456, 1998
Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ: Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: Identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89: 1260-1269, 1997
Botella LM, Puig-Kroger A, Almendro N, Sanchez-Elsner T, Munoz E, Corbi A, Bernabeu C: Identification of a functional NF-kappa B site in the platelet endothelial cell adhesion molecule-1 promoter. J Immunol 164: 1372-1378, 2000
Cabanas C, Sanchez-Madrid F, Bellon T, Figdor CG, Te Velde AA, Fernandez JM, Acevedo A, Bernabeu C: Characterization of a novel mycloid antigen regulated during differentiation of monocytic cells. Eur J Immunol 19: 1373-1378, 1989
Almendro N, Bellon T, Rius C, Lastres P, Langa C, Corbi A, Bernabeu C: Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J Immunol 157: 5411-5421, 1996
Goldberger A, Middleton KA, Newman PJ: Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines. Tissue Antigens 44: 285-293, 1994
Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A: Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 157: 1233-1241, 1996
Raab M, Daxecker H, Markovic S, Karimi A, Griesmacher A, Mueller MM: Variation of adhesion molecule expression on human umbilical vein endothelial cells upon multiple cytokine application. Clin Chim Acta 321: 11-16, 2002
Minehata K, Mukouyama YS, Sekiguchi T, Hara T, Miyajima A: Macrophage colony stimulating factor modulates the development of hematopoiesis by stimulating the differentiation of endothelial cells in the AGM region. Blood 99: 2360-2368, 2002
Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, Ali IU, Smith LE, Senger DR: Molecular profiling of angiogenesis markers. Am J Pathol 161: 35-41, 2002
Gong NL, Chowdhury SH, Wei HM, Lim YL, Chatterjee S: Lactosylceramide recruits phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. (in preparation)
Martin S, Chatterjee S: Spingolipids in atherosclerosis. Adv Cell Aging Gerontol Res 12: 71-96, 2003
Bhunia AK, Arai T, Bulkley G, Chatterjee S: Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem 273: 34349-34357, 1998
Albelda SM, Muller WA, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 114: 1059-1068, 1991
Xie Y, Muller WA: Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 90: 5569-5573, 1993
Fawcett J, Buckley C, Holness CL, Bird IN, Spragg JH, Saunders J, Harris A, Simmons DL: Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol 128: 1229-1241, 1995
Sun J, Williams J, Yan HC, Amin KM, Albelda SM, DeLisser HM: Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 271: 18561-18570, 1996
Newton JP, Buckley CD, Jones EY, Simmons DL: Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem 272: 20555-20563, 1997
Muller WA, Berman ME, Newman PJ, DeLisser HM, Albelda SM: A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med 175: 1401-1404, 1992
DeLisser HM, Yan HC, Newman PJ, Muller WA, Buck CA, Albelda SM: Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem 268: 16037-16046, 1993
Sun QH, Paddock C, Visentin GP, Zukowski MM, Muller WA, Newman PJ: Cell surface glycosaminoglycans do not serve as ligands for PECAM-1. PECAM-1 is not a heparin-binding protein. J Biol Chem 273: 11483-11490, 1998
Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA: CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130: 451-460, 1995
Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL: Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 109: 437-445, 1996
Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F: Human CD38 (ADP-ribosyl cyclase) is a counterreceptor of CD31, an Ig superfamily member. J Immunol 160: 395-402, 1998
Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178: 449-460, 1993
Berman ME, Xie Y, Muller WA: Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell trans-endothelial migration and beta 2 integrin activation. J Immunol 156: 1515-1524, 1996
Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262: 1580-1582, 1993
Bogen S, Pak J, Garifallou M, Deng X, Muller WA: Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179: 1059-1064, 1994
Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA: Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182: 1337-1343, 1995
Wakelin MW, Sanz MJ, Dewar A, Albelda SM, Larkin SW, Boughton-Smith N, Williams TJ, Nourshargh S: An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 184: 229-239, 1996
Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW: Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162: 3022-3030, 1999
Thompson RD, Noble KE, Larbi KY, Dewar A, Duncan GS, Mak TW, Nourshargh S: Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 97: 1854-1860, 2001
Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA: Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109: 383-392, 2002
Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S: CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med 176: 245-253, 1992
Leavesley DI, Oliver JM, Swart BW, Berndt MC, Haylock DN, Simmons PJ: Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells. J Immunol 153: 4673-4683, 1994
Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA: Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol 23: 2464-2471, 1993
Berman ME, Muller WA: Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 154: 299-307, 1995
Varon D, Jackson DE, Shenkman B, Dardik R, Tamarin I, Savion N, Newman PJ: Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 91: 500-507, 1998
Newman PJ, Hillery CA, Albrecht R, Parise LV, Berndt MC, Mazurov AV, Dunlop LC, Zhang J, Rittenhouse SE: Activation-dependent changes in human platelet PECAM-1: Phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol 119: 239-246, 1992
Zehnder JL, Hirai K, Shatsky M, McGregor JL, Levitt LJ, Leung LL: The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J Biol Chem 267: 5243-5249, 1992
Lastres P, Almendro N, Bellon T, Lopez-Guerrero JA, Eritja R, Bernabeu C: Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGFbeta 1 in promonocytic U-937 cells. J Immunol 153: 4206-4218, 1994
Jackson DE, Ward CM, Wang R, Newman PJ: The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1-and integrin-mediated cellular signaling. J Biol Chem 272: 6986-6993, 1997
Sagawa K, Swaim W, Zhang J, Unsworth E, Siraganian RP: Aggregation of the high affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J Biol Chem 272: 13412-13418, 1997
Lu TT, Yan LG, Madri JA: Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 93: 11808-11813, 1996
Harada N, Masuda M, Fujiwara K: Fluid flow and osmotic stress induce tyrosine phosphorylation of an endothelial cell 128 kDa surface glycoprotein. Biochem Biophys Res Commun 214: 69-74, 1995
Osawa M, Masuda M, Harada N, Lopes RB, Fujiwara K: Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells. Eur J Cell Biol 72: 229-237, 1997
Ochi H, Kume N, Nishi E, Moriwaki H, Masuda M, Fujiwara K, Kita T: Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 induced by lysophosphatidylcholine in cultured endothelial cells. Biochem Biophys Res Commun 243: 862-868, 1998
Kalra VK, Shen Y, Sultana C, Rattan V: Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. Am J Physiol 271: H2025-H2034, 1996
Schimmenti LA, Yan HC, Madri JA, Albelda SM: Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration. J Cell Physiol 153: 417-428, 1992
Pinter E, Barreuther M, Lu T, Imhof BA, Madri JA: Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol 150: 1523-1530, 1997
Pinter E, Mahooti S, Wang Y, Imhof BA, Madri JA: Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: Correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol 154: 1367-1379, 1999
Jackson DE, Kupcho KR, Newman PJ: Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem 272: 24868-24875, 1997
Hua CT, Gamble JR, Vadas MA, Jackson DE: Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J Biol Chem 273: 28332-28340, 1998
Vivier E, Daeron M: Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18: 286-291, 1997
Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, Lord JM, Wakelam MJ, Bird IN, Salmon M, Buckley CD: Differential association of cytoplasmic signaling molecules SHP-1, SHP-2, SHIP and phospholipase Cgamma1 with PECAM-1/CD31. FEBS Lett 450: 77-83, 1999
Pellegatta F, Chierchia SL, Zocchi MR: Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils. J Biol Chem 273: 27768-27771, 1998
Ilan N, Mahooti S, Rimm DL, Madri JA: PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. J Cell Sci 112: 3005-3014, 1999
Ilan N, Cheung L, Pinter E, Madri JA: Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem 275: 21435-21443, 2000
Novak A, Dedhar S: Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56: 523-537, 1999
Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, Jackson DE: Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 98: 1456-1463, 2001
Gurubhagavatula I, Amrani Y, Pratico D, Ruberg FL, Albelda SM, Panettieri RA Jr: Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J Clin Invest 101: 212-222, 1998
Ji G, O'Brien CD, Feldman M, Manevich Y, Lim P, Sun J, Albelda SM, Kotlikoff MI: PECAM-1 (CD31) regulates a hydrogen peroxide-activated nonselective cation channel in endothelial cells. J Cell Biol 157: 173-184, 2002
Jackson DE, Loo RO, Holyst MT, Newman PJ: Identification and characterization of functional cation coordination sites in platelet endothelial cell adhesion molecule-1. Biochemistry 36: 9395-9404, 1997
Evans PC, Taylor ER, Kilshaw PJ: Signaling through CD31 protects endothelial cells from apoptosis. Transplantation 71: 457-460, 2001
Ilan N, Mohsenin A, Cheung L, Madri JA: PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. Faseb J 15: 362-372, 2001
Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J: Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418: 200-203, 2002
Newman DK, Hoffman SL, Kotamraju S, Kalyanaraman B, Newman P: Nitration of the tyrosine-based inhibitory motif of PECAM-1 promotes binding of the protein tyrosine phosphatase, SHP-2. ATVB Annual Meeting Proceedings. 6: (abstr), 10, 2002
Wilkinson R, Lyons AB, Roberts D, Wong MX, Bartley PA, Jackson DE: Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100: 184-193, 2002
Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171: 223-229, 1993
Masuda M, Takahashi H: Adhesion of leukocytes to endothelial cells in atherosclerosis. Rinsho Byori 46: 1149-1155, 1998
Wenzel K, Baumann G, Felix SB: The homozygous combination of Leu125Val and Ser563Asn polymorphisms in the PECAM1 (CD31) gene is associated with early severe coronary heart disease. Hum Mutat 14: 545, 1999
Gardemann A, Knapp A, Katz N, Tillmanns H, Haberbosch W: No evidence for the CD31 C/G gene polymorphism as an independent risk factor of coronary heart disease. Thromb Haemost 83: 629, 2000
Sasaoka T, Kimura A, Hohta SA, Fukuda N, Kurosawa T, Izumi T: Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (PECAM-1) gene,Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese. Ann NY Acad Sci 947: 259-269, 2001
Andreotti F, Porto I, Crea F, Maseri A: Inflammatory gene polymorphisms and ischaemic heart disease: Review of population association studies. Heart 87: 107-112, 2002
Mahooti S, Graesser D, Patil S, Newman P, Duncan G, Mak T, Madri JA: PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol 157: 75-81, 2000
Vollmar B, Schmits R, Kunz D, Menger MD: Lack of in vivo function of CD31 in vascular thrombosis. Thromb Haemost 85: 160-164, 2001
Matsumura T, Wolff K, Petzelbauer P: Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158: 3408-3416, 1997
Cao G, O'Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM: Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 282: C1181-1190, 2002
Tang DG, Chen YQ, Newman PJ, Shi L, Gao X, Diglio CA, Honn KV: Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 268: 22883-22894, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gong, N., Chatterjee, S. Platelet endothelial cell adhesion molecule in cell signaling and thrombosis. Mol Cell Biochem 253, 151–158 (2003). https://doi.org/10.1023/A:1026016628386
Issue Date:
DOI: https://doi.org/10.1023/A:1026016628386